These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6521962

  • 1. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease.
    Perry EK, Perry RH, Candy JM, Fairbairn AF, Blessed G, Dick DJ, Tomlinson BE.
    Neurosci Lett; 1984 Oct 26; 51(3):353-7. PubMed ID: 6521962
    [Abstract] [Full Text] [Related]

  • 2. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH, Perry EK, Smith CJ, Xuereb JH, Irving D, Whitford CA, Candy JM, Cross AJ.
    J Neural Transm Suppl; 1987 Oct 26; 24():131-6. PubMed ID: 2824687
    [Abstract] [Full Text] [Related]

  • 3. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
    Cheng AV, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, Edwardson JA, Perry RH, Perry EK.
    J Neurol Sci; 1991 Nov 26; 106(1):50-5. PubMed ID: 1779239
    [Abstract] [Full Text] [Related]

  • 4. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
    Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH.
    J Neurol Neurosurg Psychiatry; 1985 May 26; 48(5):413-21. PubMed ID: 3998751
    [Abstract] [Full Text] [Related]

  • 5. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
    Perry EK, Smith CJ, Court JA, Perry RH.
    J Neural Transm Park Dis Dement Sect; 1990 May 26; 2(3):149-58. PubMed ID: 2175197
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reductions in acetylcholine and nicotine binding in several degenerative diseases.
    Whitehouse PJ, Martino AM, Marcus KA, Zweig RM, Singer HS, Price DL, Kellar KJ.
    Arch Neurol; 1988 Jul 26; 45(7):722-4. PubMed ID: 3390025
    [Abstract] [Full Text] [Related]

  • 10. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.
    Araujo DM, Lapchak PA.
    Neuroscience; 1994 Aug 26; 61(4):745-54. PubMed ID: 7838374
    [Abstract] [Full Text] [Related]

  • 11. Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
    Ruberg M, Mayo W, Brice A, Duyckaerts C, Hauw JJ, Simon H, LeMoal M, Agid Y.
    Neuroscience; 1990 Aug 26; 35(2):327-33. PubMed ID: 2166243
    [Abstract] [Full Text] [Related]

  • 12. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
    Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D.
    Ann N Y Acad Sci; 1991 Aug 26; 640():197-202. PubMed ID: 1723256
    [Abstract] [Full Text] [Related]

  • 13. Serotonin receptor changes in dementia of the Alzheimer type.
    Cross AJ, Crow TJ, Ferrier IN, Johnson JA, Bloom SR, Corsellis JA.
    J Neurochem; 1984 Dec 26; 43(6):1574-81. PubMed ID: 6208336
    [Abstract] [Full Text] [Related]

  • 14. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease.
    Kerwin JM, Morris CM, Perry RH, Perry EK.
    Neurosci Lett; 1992 Aug 31; 143(1-2):101-4. PubMed ID: 1436650
    [Abstract] [Full Text] [Related]

  • 15. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
    Rinne JO, Lönnberg P, Marjamäki P, Rinne UK.
    Brain Res; 1989 Apr 03; 483(2):402-6. PubMed ID: 2706531
    [Abstract] [Full Text] [Related]

  • 16. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF, Clevens RA, Chattha GK, MacGarvey UM, Mazurek MF, Gabriel SM.
    J Neurochem; 1988 Dec 03; 51(6):1935-41. PubMed ID: 2460590
    [Abstract] [Full Text] [Related]

  • 17. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.
    Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G.
    J Neurol Neurosurg Psychiatry; 1987 Jun 03; 50(6):806-9. PubMed ID: 2956364
    [Abstract] [Full Text] [Related]

  • 18. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B, Hauw JJ, Ruberg M, Serdaru M, Javoy-Agid F, Agid Y.
    Rev Neurol (Paris); 1985 Jun 03; 141(3):184-93. PubMed ID: 4001706
    [Abstract] [Full Text] [Related]

  • 19. Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.
    Cross AJ, Slater P, Simpson M, Royston C, Deakin JF, Perry RH, Perry EK.
    Neurosci Lett; 1987 Aug 18; 79(1-2):213-7. PubMed ID: 2823192
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.